NYSE:GEN - Genesis HealthCare Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.82 +0.09 (+5.20 %)
(As of 05/20/2018 12:06 PM ET)
Previous Close$1.82
Today's Range$1.70 - $1.92
52-Week Range$0.60 - $2.29
Volume2.27 million shs
Average Volume395,008 shs
Market Capitalization$290.19 million
P/E Ratio-0.86
Dividend YieldN/A
Beta0.9

About Genesis HealthCare (NYSE:GEN)

Genesis HealthCare logoGenesis Healthcare, Inc. is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services. As of December 31, 2016, the Company offered inpatient services through its network of 499 skilled nursing and assisted/senior living facilities across 34 states, consisting of 473 skilled nursing facilities and 26 stand-alone assisted/senior living facilities. Its services focus primarily on the medical and physical issues facing elderly patients and are provided by its skilled nursing companies, assisted or senior living communities, integrated and third-party rehabilitation therapy business, and other ancillary services.

Receive GEN News and Ratings via Email

Sign-up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Skilled nursing care facilities
Sub-IndustryN/A
SectorMedical
SymbolNYSE:GEN
CUSIPN/A
Phone610-444-6350

Debt

Debt-to-Equity Ratio-2.80
Current Ratio1.11
Quick Ratio1.11

Price-To-Earnings

Trailing P/E Ratio-0.86
Forward P/E Ratio-1.31
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.37 billion
Price / Sales0.05
Cash Flow$2.60 per share
Price / Cash0.70
Book Value($11.21) per share
Price / Book-0.16

Profitability

EPS (Most Recent Fiscal Year)($2.11)
Net Income$-578,980,000.00
Net Margins-11.29%
Return on EquityN/A
Return on Assets-2.73%

Miscellaneous

Employees68,700
Outstanding Shares159,450,000

Genesis HealthCare (NYSE:GEN) Frequently Asked Questions

What is Genesis HealthCare's stock symbol?

Genesis HealthCare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."

How were Genesis HealthCare's earnings last quarter?

Genesis HealthCare (NYSE:GEN) announced its earnings results on Thursday, May, 10th. The company reported ($0.70) EPS for the quarter, missing the consensus estimate of ($0.36) by $0.34. The business had revenue of $1.30 billion for the quarter, compared to analysts' expectations of $1.32 billion. During the same quarter in the prior year, the business earned ($0.55) EPS. View Genesis HealthCare's Earnings History.

What price target have analysts set for GEN?

4 brokers have issued twelve-month price objectives for Genesis HealthCare's stock. Their forecasts range from $2.00 to $2.00. On average, they anticipate Genesis HealthCare's stock price to reach $2.00 in the next twelve months. View Analyst Ratings for Genesis HealthCare.

Who are some of Genesis HealthCare's key competitors?

Who are Genesis HealthCare's key executives?

Genesis HealthCare's management team includes the folowing people:
  • Robert H. Fish, Chairman of the Board
  • George V. Hager Jr., Chief Executive Officer, Director
  • Thomas DiVittorio, Chief Financial Officer
  • Paul David Bach, Chief Operating Officer
  • Jeanne Phillips, Chief Human Resource Officer, Senior Vice President
  • , Bio & Compensation - 
  • David C. Almquist, Executive Vice President, President - West and East Divisions
  • Richard P. Blinn, Executive Vice President, President - Northeast Division and Southeast Divisions
  • JoAnne Reifsnyder Ph.D., Executive Vice President - Clinical Operations, Chief Nursing Officer
  • Richard L. Castor, Senior Vice President, Chief Information Officer
  • Michael S. Sherman, Senior Vice President, General Counsel, Assistant Treasurer, Secretary

Has Genesis HealthCare been receiving favorable news coverage?

News stories about GEN stock have been trending somewhat positive this week, according to Accern Sentiment. The research group scores the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Genesis HealthCare earned a news impact score of 0.05 on Accern's scale. They also gave news stories about the company an impact score of 45.13 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

Who are Genesis HealthCare's major shareholders?

Genesis HealthCare's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Columbia Pacific Advisors LLC (3.86%), First Washington CORP (1.88%), V3 Capital Management L.P. (1.60%), BlackRock Inc. (1.44%), Glassman Wealth Services (0.70%) and Prescott Group Capital Management L.L.C. (0.37%). Company insiders that own Genesis HealthCare stock include Daniel Allen Hirschfeld, George V Hager Jr, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Institutional Ownership Trends for Genesis HealthCare.

Which major investors are selling Genesis HealthCare stock?

GEN stock was sold by a variety of institutional investors in the last quarter, including Prescott Group Capital Management L.L.C., Columbia Pacific Advisors LLC, JPMorgan Chase & Co., First Washington CORP, Forward Management LLC and Northern Trust Corp. Company insiders that have sold Genesis HealthCare company stock in the last year include Daniel Allen Hirschfeld, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Insider Buying and Selling for Genesis HealthCare.

Which major investors are buying Genesis HealthCare stock?

GEN stock was bought by a variety of institutional investors in the last quarter, including Glassman Wealth Services, V3 Capital Management L.P., BlackRock Inc., Schwab Charles Investment Management Inc., Millennium Management LLC, California Public Employees Retirement System and BSW Wealth Partners. View Insider Buying and Selling for Genesis HealthCare.

How do I buy shares of Genesis HealthCare?

Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Genesis HealthCare's stock price today?

One share of GEN stock can currently be purchased for approximately $1.82.

How big of a company is Genesis HealthCare?

Genesis HealthCare has a market capitalization of $290.19 million and generates $5.37 billion in revenue each year. The company earns $-578,980,000.00 in net income (profit) each year or ($2.11) on an earnings per share basis. Genesis HealthCare employs 68,700 workers across the globe.

How can I contact Genesis HealthCare?

Genesis HealthCare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected]


MarketBeat Community Rating for Genesis HealthCare (GEN)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  153 (Vote Outperform)
Underperform Votes:  224 (Vote Underperform)
Total Votes:  377
MarketBeat's community ratings are surveys of what our community members think about Genesis HealthCare and other stocks. Vote "Outperform" if you believe GEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GEN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Genesis HealthCare (NYSE:GEN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Genesis HealthCare in the last 12 months. Their average twelve-month price target is $2.00, suggesting that the stock has a possible upside of 9.89%. The high price target for GEN is $2.00 and the low price target for GEN is $2.00. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyBuy
Consensus Rating Score: 2.252.332.502.50
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.00$2.00$2.00$2.00
Price Target Upside: 9.89% upside30.72% upside96.08% upside96.08% upside

Genesis HealthCare (NYSE:GEN) Consensus Price Target History

Price Target History for Genesis HealthCare (NYSE:GEN)

Genesis HealthCare (NYSE:GEN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/24/2018Stifel NicolausSet Price TargetHold$2.00MediumView Rating Details
3/19/2018StephensReiterated RatingHold$2.00HighView Rating Details
9/13/2017Royal Bank of CanadaReiterated RatingHold$2.00LowView Rating Details
7/5/2017Cantor FitzgeraldInitiated CoverageOverweightHighView Rating Details
9/19/2016Bank of AmericaSet Price TargetSell$1.80N/AView Rating Details
8/22/2016UBSReiterated RatingSellN/AView Rating Details
(Data available from 5/20/2016 forward)

Earnings

Genesis HealthCare (NYSE:GEN) Earnings History and Estimates Chart

Earnings by Quarter for Genesis HealthCare (NYSE:GEN)

Genesis HealthCare (NYSE:GEN) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.39 EPS
Next Year EPS Consensus Estimate: $-1.35 EPS

Genesis HealthCare (NYSE GEN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2018Q1 2018($0.36)($0.70)$1.32 billion$1.3011 billionViewN/AView Earnings Details
3/16/2018Q4 2017($0.31)($0.36)$1.34 billion$1.3279 billionViewN/AView Earnings Details
11/8/2017Q3 2017($0.30)($0.36)$1.3430 billion$1.3155 billionViewN/AView Earnings Details
8/8/2017Q2 2017($0.26)($0.32)$1.3660 billion$1.3413 billionViewN/AView Earnings Details
5/9/2017Q1 17($0.25)($0.50)$1.4010 billion$1.3891 billionViewListenView Earnings Details
3/6/2017Q4 2016($0.64)$1.4029 billionViewN/AView Earnings Details
11/3/2016Q3($0.40)($0.23)$1.39 billion$1.4190 billionViewN/AView Earnings Details
8/4/2016Q2$0.01($0.26)$1.40 billion$1.44 billionViewN/AView Earnings Details
5/9/2016Q1$0.03($0.01)$1.43 billion$1.47 billionViewN/AView Earnings Details
2/22/2016Q4 2015($0.05)($0.05)$1.4407 billionViewN/AView Earnings Details
11/5/2015Q315$0.07$0.07$1.42 billion$1.42 billionViewN/AView Earnings Details
8/6/2015Q215$0.09$0.14$1.43 billion$1.41 billionViewN/AView Earnings Details
5/7/2015Q1 2015$0.04$0.07$1.4291 billion$1.3430 billionViewN/AView Earnings Details
2/19/2015Q412$0.14$0.14$209.50 million$1.19 billionViewN/AView Earnings Details
11/3/2014Q314$0.07$0.13$208.10 million$208.60 millionViewListenView Earnings Details
8/11/2014Q214$0.06$0.07$209.15 million$207.00 millionViewListenView Earnings Details
5/5/2014Q114$0.07$0.06$210.39 million$207.30 millionViewListenView Earnings Details
2/11/2014Q413$0.10$0.06$215.35 million$208.30 millionViewListenView Earnings Details
11/4/2013Q313$0.10$0.06$214.47 million$212.40 millionViewN/AView Earnings Details
8/5/2013Q2 2013$0.16$0.09$219.58 million$213.70 millionViewN/AView Earnings Details
5/6/2013Q1 2013$0.18$0.10$222.52 million$218.90 millionViewN/AView Earnings Details
2/11/2013Q4 2012$0.19$0.16$219.67 million$219.20 millionViewN/AView Earnings Details
11/9/2012Q312$0.03$0.18$935.06 millionViewN/AView Earnings Details
11/5/2012Q312$0.20$0.21$218.92 million$216.60 millionViewN/AView Earnings Details
8/8/2012$0.19$0.18ViewN/AView Earnings Details
5/2/2012$0.19$0.17ViewN/AView Earnings Details
2/13/2012$0.15$0.19ViewN/AView Earnings Details
10/31/2011$0.30$0.32ViewN/AView Earnings Details
8/1/2011$0.31$0.30ViewN/AView Earnings Details
5/3/2011$0.30$0.34ViewN/AView Earnings Details
2/14/2011$0.28$0.31ViewN/AView Earnings Details
11/1/2010Q3 2010$0.20$0.25ViewN/AView Earnings Details
8/5/2010Q2 2010$0.21$0.24ViewN/AView Earnings Details
5/3/2010Q1 2010$0.23$0.24ViewN/AView Earnings Details
2/8/2010Q4 2009$0.23$0.25ViewN/AView Earnings Details
11/3/2009Q3 2009$0.22$0.25ViewN/AView Earnings Details
8/4/2009Q2 2009$0.25$0.25ViewN/AView Earnings Details
5/5/2009Q1 2009$0.27$0.29ViewN/AView Earnings Details
2/10/2009Q4 2008$0.27$0.28ViewN/AView Earnings Details
11/6/2008Q3 2008$0.25$0.26ViewN/AView Earnings Details
8/5/2008Q2 2008$0.24$0.24ViewN/AView Earnings Details
5/6/2008Q1 2008$0.23$0.23ViewN/AView Earnings Details
2/12/2008Q4 2007$0.23$0.21ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Genesis HealthCare (NYSE:GEN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Genesis HealthCare (NYSE GEN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 57.59%
Institutional Ownership Percentage: 18.15%
Insider Trading History for Genesis HealthCare (NYSE:GEN)
Insider Trading History for Genesis HealthCare (NYSE:GEN)

Genesis HealthCare (NYSE GEN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/14/2017Joanne Susan ReifsnyderEVPSell5,269$1.73$9,115.37View SEC Filing  
6/14/2017Michael Scott ShermanSVPSell3,903$1.73$6,752.19View SEC Filing  
6/14/2017Paul David BachCOOSell6,100$1.73$10,553.00View SEC Filing  
6/14/2017Stephen Scott YoungVPSell3,799$1.73$6,572.27View SEC Filing  
6/14/2017Thomas DivittorioCFOSell6,341$1.73$10,969.93View SEC Filing  
6/7/2017Daniel Allen HirschfeldCOOSell2,895$1.61$4,660.95View SEC Filing  
6/7/2017Joanne Susan ReifsnyderEVPSell2,383$1.61$3,836.63View SEC Filing  
6/7/2017Michael Scott ShermanSVPSell1,824$1.61$2,936.64View SEC Filing  
6/7/2017Stephen Scott YoungVPSell1,541$1.61$2,481.01View SEC Filing  
6/7/2017Thomas DivittorioCFOSell2,900$1.61$4,669.00View SEC Filing  
8/29/2016Stephen Scott YoungVPSell10,000$2.38$23,800.00View SEC Filing  
6/8/2016Daniel Allen HirschfeldCOOSell3,009$1.72$5,175.48488,220View SEC Filing  
6/8/2016George V Hager JrCEOSell6,031$1.72$10,373.321,542,780View SEC Filing  
6/8/2016Joanne Susan ReifsnyderEVPSell2,207$1.72$3,796.04286,468View SEC Filing  
6/8/2016Michael Scott ShermanSVPSell1,919$1.72$3,300.68423,220View SEC Filing  
6/8/2016Stephen Scott YoungVPSell1,621$1.72$2,788.12172,495View SEC Filing  
6/8/2016Thomas DivittorioCFOSell3,051$1.72$5,247.72509,220View SEC Filing  
11/12/2015James V MckeonDirectorBuy10,000$4.15$41,500.0029,802View SEC Filing  
11/11/2015Thomas DivittorioCFOBuy20,000$4.34$86,800.00387,220View SEC Filing  
11/14/2013Boyd HendricksonCEOSell48,774$5.02$244,845.48265,430View SEC Filing  
8/6/2013Boyd W HendricksonCEOSell4,983$6.03$30,047.49View SEC Filing  
8/5/2013Boyd W HendricksonCEOSell24,671$6.49$160,114.79View SEC Filing  
8/2/2013Boyd W HendricksonCEOSell45,346$6.58$298,376.68View SEC Filing  
7/2/2013Boyd W HendricksonCEOSell29,988$6.46$193,722.48View SEC Filing  
7/1/2013Boyd W HendricksonCEOSell28,112$6.61$185,820.32View SEC Filing  
11/1/2012Boyd W HendricksonCEOSell1,567$8.00$12,536.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Genesis HealthCare (NYSE GEN) News Headlines

Source:
DateHeadline
FOCUS-A bid to save $300 million at HCR ManorCare, and disrupt U.S. healthcareFOCUS-A bid to save $300 million at HCR ManorCare, and disrupt U.S. healthcare
finance.yahoo.com - May 15 at 8:46 AM
Free Stock Performance Review on Envision Healthcare and Three More Long-Term Care Facilities StocksFree Stock Performance Review on Envision Healthcare and Three More Long-Term Care Facilities Stocks
finance.yahoo.com - May 14 at 8:46 AM
Genesis HealthCare (GEN) Announces Quarterly  Earnings Results, Misses Estimates By $0.34 EPSGenesis HealthCare (GEN) Announces Quarterly Earnings Results, Misses Estimates By $0.34 EPS
www.americanbankingnews.com - May 12 at 1:35 PM
Genesis Healthcares (GEN) CEO George Hager on Q1 2018 Results - Earnings Call TranscriptGenesis Healthcare's (GEN) CEO George Hager on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 5:40 PM
Edited Transcript of GEN earnings conference call or presentation 10-May-18 12:30pm GMTEdited Transcript of GEN earnings conference call or presentation 10-May-18 12:30pm GMT
finance.yahoo.com - May 11 at 8:48 AM
Genesis Healthcare EPS of -$0.70Genesis Healthcare EPS of -$0.70
seekingalpha.com - May 10 at 8:37 AM
BRIEF-Genesis Healthcare Says Qtrly Loss Per Share Attributable To Co $0.70BRIEF-Genesis Healthcare Says Qtrly Loss Per Share Attributable To Co $0.70
www.reuters.com - May 10 at 8:37 AM
Genesis HealthCare Reports First Quarter 2018 ResultsGenesis HealthCare Reports First Quarter 2018 Results
finance.yahoo.com - May 10 at 8:37 AM
Genesis Healthcare: 1Q Earnings SnapshotGenesis Healthcare: 1Q Earnings Snapshot
finance.yahoo.com - May 10 at 8:37 AM
Interim Report First Quarter 2018Interim Report First Quarter 2018
finance.yahoo.com - May 8 at 5:25 PM
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Newly Diagnosed Multiple MyelomaGenmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Newly Diagnosed Multiple Myeloma
finance.yahoo.com - May 8 at 8:30 AM
Genesis Healthcare Expects to Release First Quarter 2018 Results on May 10, 2018Genesis Healthcare Expects to Release First Quarter 2018 Results on May 10, 2018
finance.yahoo.com - May 8 at 8:30 AM
Genesis HealthCare (GEN) to Release Quarterly Earnings on MondayGenesis HealthCare (GEN) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - May 2 at 8:10 PM
Form DEF 14A Genesis Healthcare, Inc. For: Jun 06Form DEF 14A Genesis Healthcare, Inc. For: Jun 06
www.streetinsider.com - April 29 at 8:39 AM
Form DEFA14A Genesis Healthcare, Inc.Form DEFA14A Genesis Healthcare, Inc.
www.streetinsider.com - April 29 at 8:39 AM
What You Must Know About Genomed Spólka Akcyjna’s (WSE:GEN) Major InvestorsWhat You Must Know About Genomed Spólka Akcyjna’s (WSE:GEN) Major Investors
finance.yahoo.com - April 26 at 8:28 AM
Genmab Announces Data to be Presented at 2018 ASCO Annual MeetingGenmab Announces Data to be Presented at 2018 ASCO Annual Meeting
finance.yahoo.com - April 25 at 5:20 PM
Citigroup Inc., Genesis Healthcare, Molson Coors Brewing Co., Tempur Sealy International, Overstock.com, and 75 Other Companies Join NACD in Q1 2018Citigroup Inc., Genesis Healthcare, Molson Coors Brewing Co., Tempur Sealy International, Overstock.com, and 75 Other Companies Join NACD in Q1 2018
globenewswire.com - April 24 at 5:26 PM
$30M deal: Genesis to sell 51% stake in China subsidiary$30M deal: Genesis to sell 51% stake in China subsidiary
finance.yahoo.com - April 24 at 5:26 PM
Stifel Nicolaus Reiterates "$2.00" Price Target for Genesis HealthCare (GEN)Stifel Nicolaus Reiterates "$2.00" Price Target for Genesis HealthCare (GEN)
www.americanbankingnews.com - April 24 at 4:18 PM
Reviewing Ensign Group (ENSG) & Genesis HealthCare (GEN)Reviewing Ensign Group (ENSG) & Genesis HealthCare (GEN)
www.americanbankingnews.com - April 24 at 3:32 PM
Sabra: A Healthcare REIT With Tailwinds And A 10.5% DividendSabra: A Healthcare REIT With Tailwinds And A 10.5% Dividend
seekingalpha.com - April 23 at 5:04 PM
Genesis HealthCare Sells 51% Stake in Chinese Subsidiary GRS-HS to Riswein Health Industry Investment Co., LtdGenesis HealthCare Sells 51% Stake in Chinese Subsidiary GRS-HS to Riswein Health Industry Investment Co., Ltd
finance.yahoo.com - April 23 at 5:04 PM
-$0.31 EPS Expected for Genesis HealthCare (GEN) This Quarter-$0.31 EPS Expected for Genesis HealthCare (GEN) This Quarter
www.americanbankingnews.com - April 20 at 11:28 AM
Genesis HealthCare (GEN) Cut to Strong Sell at ValuEngineGenesis HealthCare (GEN) Cut to Strong Sell at ValuEngine
www.americanbankingnews.com - April 18 at 4:44 PM
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2018Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2018
finance.yahoo.com - April 17 at 8:47 AM
Genesis selling off 2 dozen skilled nursing facilities in TexasGenesis selling off 2 dozen skilled nursing facilities in Texas
finance.yahoo.com - April 12 at 5:23 PM
Centers Health Care Hires Heidi Hendrix, RN, As New Chief Nursing OfficerCenters Health Care Hires Heidi Hendrix, RN, As New Chief Nursing Officer
www.bizjournals.com - April 12 at 8:59 AM
Genesis Healthcare to divest 23 nursing facilitiesGenesis Healthcare to divest 23 nursing facilities
seekingalpha.com - April 12 at 8:59 AM
Can Genomed Spólka Akcyjna (WSE:GEN) Improve Your Portfolio Returns?Can Genomed Spólka Akcyjna (WSE:GEN) Improve Your Portfolio Returns?
finance.yahoo.com - April 12 at 8:59 AM
Genesis Energy Limited (NZE:GNE): Time For A Financial Health CheckGenesis Energy Limited (NZE:GNE): Time For A Financial Health Check
finance.yahoo.com - April 11 at 8:46 AM
Passing of Genmab A/S’ Annual General MeetingPassing of Genmab A/S’ Annual General Meeting
finance.yahoo.com - April 10 at 5:19 PM
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in GenmabConstitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab
finance.yahoo.com - April 10 at 5:19 PM
Should You Expect Genomed Spólka Akcyjna (WSE:GEN) To Continue Delivering An ROE Of 29.39%?Should You Expect Genomed Spólka Akcyjna (WSE:GEN) To Continue Delivering An ROE Of 29.39%?
finance.yahoo.com - April 4 at 4:02 PM
Capital Increase in Genmab as a Result of Employee Warrant ExerciseCapital Increase in Genmab as a Result of Employee Warrant Exercise
finance.yahoo.com - April 3 at 5:22 PM
ValuEngine Downgrades Genesis Healthcare (GEN) to HoldValuEngine Downgrades Genesis Healthcare (GEN) to Hold
www.americanbankingnews.com - April 3 at 2:58 PM
Quorum Health (QHC) Names Terry Allison Rappuhn as New Chair; William M. Gracey ResignsQuorum Health (QHC) Names Terry Allison Rappuhn as New Chair; William M. Gracey Resigns
www.streetinsider.com - March 26 at 8:36 AM
Quorum Health (QHC) Names Terry Allison Rappuhn as New Chair; William M. Gracey Resigns - StreetInsider.comQuorum Health (QHC) Names Terry Allison Rappuhn as New Chair; William M. Gracey Resigns - StreetInsider.com
www.streetinsider.com - March 24 at 9:01 AM
Genesis Healthcare riding nursing-home turbulence [Philly.com]Genesis Healthcare riding nursing-home turbulence [Philly.com]
www.bloomberg.com - March 22 at 5:25 PM
Genesis Rehab Services Achieves “World Class” Net Promoter ScoreGenesis Rehab Services Achieves “World Class” Net Promoter Score
finance.yahoo.com - March 22 at 5:25 PM
Genesis Healthcare (GEN) & Its Competitors Head-To-Head SurveyGenesis Healthcare (GEN) & Its Competitors Head-To-Head Survey
www.americanbankingnews.com - March 22 at 1:38 PM
Genesis Healthcare (GEN) Rating Reiterated by StephensGenesis Healthcare (GEN) Rating Reiterated by Stephens
www.americanbankingnews.com - March 19 at 9:30 PM
Should You Be Tempted To Buy Genomed Spólka Akcyjna (WSE:GEN) Because Of Its PE Ratio?Should You Be Tempted To Buy Genomed Spólka Akcyjna (WSE:GEN) Because Of Its PE Ratio?
finance.yahoo.com - March 19 at 5:08 PM
Genesis Healthcare, Inc. (GEN) PT Raised to $2 at Stephens - StreetInsider.comGenesis Healthcare, Inc. (GEN) PT Raised to $2 at Stephens - StreetInsider.com
www.streetinsider.com - March 19 at 8:36 AM
Canon Medical Systems’ Aquilion ONE / GENESIS Edition Delivers Full Suite of Acute Stroke SolutionsCanon Medical Systems’ Aquilion ONE / GENESIS Edition Delivers Full Suite of Acute Stroke Solutions
www.bizjournals.com - March 18 at 8:31 AM
Edited Transcript of GEN earnings conference call or presentation 16-Mar-18 12:30pm GMTEdited Transcript of GEN earnings conference call or presentation 16-Mar-18 12:30pm GMT
finance.yahoo.com - March 17 at 8:42 AM
Genesis Healthcare (GEN) Presents At Barclays Global Healthcare Conference 2018 - SlideshowGenesis Healthcare (GEN) Presents At Barclays Global Healthcare Conference 2018 - Slideshow
seekingalpha.com - March 16 at 6:16 PM
Genesis Healthcare reports 4Q lossGenesis Healthcare reports 4Q loss
finance.yahoo.com - March 16 at 8:34 AM
Genesis HealthCare Reports Fourth Quarter and Fiscal Year End 2017 ResultsGenesis HealthCare Reports Fourth Quarter and Fiscal Year End 2017 Results
finance.yahoo.com - March 16 at 8:34 AM
An Intrinsic Calculation For Genesis Healthcare Inc (NYSE:GEN) Shows It’s 38% UndervaluedAn Intrinsic Calculation For Genesis Healthcare Inc (NYSE:GEN) Shows It’s 38% Undervalued
finance.yahoo.com - March 13 at 7:07 PM

SEC Filings

Genesis HealthCare (NYSE:GEN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Genesis HealthCare (NYSE:GEN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Genesis HealthCare (NYSE GEN) Stock Chart for Sunday, May, 20, 2018

Loading chart…

This page was last updated on 5/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.